Early Biomarker Of Insulin Resistance And Glucose Intolerance Identified In A Nondiabetic Population

Metabolon, Inc., the leader in metabolomics-based biomarker discovery and analysis, announced the publication of research that identified a novel, early biomarker for insulin resistance and glucose intolerance in a nondiabetic population. Co-authored by physicians and scientists from EGIR (European Group for the Study of Insulin Resistance) and Metabolon, the paper, “alpha-hydroxybutyrate Is an Early Biomarker [...]

British Indians Have Fewer Cancers Than White British Population

British Indians have fewer cases of many different cancers including breast, prostate, colon and lung than the British white population, according to new research published in the British Journal of Cancer1 today.
Figures from the study also reveal the cancer rates in British Indians are higher than rates in India, except for cancers of the head and neck.
Researchers [...]

Scientists Show How Brain Tumors Outsmart Drugs

Researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine and Moores UCSD Cancer Center have shown one way in which gliomas, a deadly type of brain tumor, can evade drugs aimed at blocking a key cell signaling protein, epidermal growth factor receptor (EGFR),that is crucial [...]

C-Reactive Protein Levels Correlate With Future Risk Of Heart Attack, Stroke And Cancers, But Causality Seems Unlikely

There has been intense interest among researchers during the past decade about whether blood concentrations of C-reactive protein (CRP) – a sensitive indicator of tissue injury inflammation produced by the liver – is a causal factor in heart disease. Earlier studies had suggested that this protein might be as important in the causation ofheart attack [...]

Blocking Tissue Stiffening Enzyme Could Be Key To Preventing Aggressive Cancers

A team of scientists from the US and the UK have shown that blocking an enzyme called lysyl oxidase (LOX) that causes tissue to stiffen reduces the likelihood of abnormal but non-malignant breast tissue turning into tumors, suggesting that LOX and similar enzymes could be new targets for effective anti-cancer drug therapies.